⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18589688 | 0.77 | TSHR (0.36) | — | |
| SCHEMBL18608500 | 0.77 | TSHR (0.36) | — | |
| SCHEMBL23024244 | 0.71 | DPP4 (0.32) | — | |
| SCHEMBL16565905 | 0.71 | DPP4 (0.32) | — | |
| SCHEMBL2540687 | 0.71 | DPP4 (0.32) | — | |
| SCHEMBL18577564 | 0.70 | PLG (0.34) | — | |
| SCHEMBL16554547 | 0.69 | — | — | |
| SCHEMBL20555742 | 0.67 | CHRM1 (0.34) | — | |
| SCHEMBL8512910 | 0.63 | SPR (0.32) | — | |
| SCHEMBL8512905 | 0.63 | SPR (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3344626-B9 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2021-08-11 | — | — | EP | disclosed |
| EP-3344627-B9 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2021-08-04 | — | — | EP | disclosed |
| EP-3344614-B9 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2021-07-28 | — | — | EP | disclosed |
| EP-3344628-B9 | THERAPEUTIC COMPOUNDS AND SYNTHESIS | JANSSEN PHARMACEUTICA NV (BE) | 2021-06-30 | — | — | EP | disclosed |
| US-10766898-B2 | Therapeutic compound for pain and synthesis thereof | JANSSEN PHARMACEUTICA NV (BE) | 2020-09-08 | — | — | US | disclosed |
| EP-3344628-B1 | THERAPEUTIC COMPOUNDS AND SYNTHESIS | JANSSEN PHARMACEUTICA NV (BE) | 2020-07-15 | — | — | EP | disclosed |
| EP-3344626-B1 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2020-07-08 | — | — | EP | disclosed |
| EP-3344614-B1 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2020-07-08 | — | — | EP | disclosed |
| EP-3344627-B1 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2020-07-01 | — | — | EP | disclosed |
| US-10358448-B2 | Therapeutic compounds for pain and synthesis thereof | JANSSEN PHARMACEUTICA NV (BE) | 2019-07-23 | — | — | US | disclosed |
| US-20170066770-A1 | THERAPEUTIC COMPOUND FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-09 | — | — | US | disclosed |
| US-20170066767-A1 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-09 | — | — | US | disclosed |
| US-20170066769-A1 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-09 | — | — | US | disclosed |
| US-20170066760-A1 | THERAPEUTIC COMPOUNDS AND SYNTHESIS | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-09 | — | — | US | disclosed |
| US-20170066768-A1 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-09 | — | — | US | disclosed |
| WO-2017040764-A1 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-09 | — | — | WO | disclosed |
| WO-2017040770-A1 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-09 | — | — | WO | disclosed |
| WO-2017040772-A1 | THERAPEUTIC COMPOUNDS AND SYNTHESIS | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-09 | — | — | WO | disclosed |
| WO-2017040778-A1 | THERAPEUTIC COMPOUND FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-09 | — | — | WO | disclosed |
| WO-2017040767-A1 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-09 | — | — | WO | disclosed |